|
Dr. Tefferi announced that there will be 5 JAK2 mutation inhibitor drug candidates entering clinical trials over the next 12 months. Clinical trials are expected to open shortly on the first of these drug candidates. Details will be available in the Conference summaries which are coming soon.
Order the conference DVD
|
